Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

A phase II study of paclitaxel (P) in patients with refractory lymphomas

A phase II study of paclitaxel (P) in patients with refractory lymphomas. Proc Annu Meet Am Soc Clin Oncol. 1996; 15:A1286.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.